CUSIP: 30233M107
What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 30233M107:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2019 Q3 | 0 | $0 | -$4,451,996 | 0 | |
| 2019 Q2 | 18,560,037 | $4,452,000 | +$70,442 | $0.24 | 16 |
| 2019 Q1 | 18,266,351 | $5,571,000 | +$112,612 | $0.30 | 13 |
| 2018 Q4 | 17,864,795 | $8,309,000 | +$200,979 | $0.47 | 13 |
| 2018 Q3 | 17,529,808 | $5,436,000 | +$51,789 | $0.31 | 19 |
| 2018 Q2 | 17,281,044 | $9,160,000 | +$8,313,807 | $0.53 | 17 |
| 2018 Q1 | 1,568,779 | $597,000 | -$149,622 | $0.38 | 15 |
| 2017 Q4 | 1,805,534 | $1,932,000 | -$270,033 | $1.07 | 15 |
| 2017 Q3 | 2,052,803 | $2,402,000 | -$208,322 | $1.17 | 10 |
| 2017 Q2 | 2,233,018 | $3,060,000 | +$2,563,061 | $1.38 | 8 |
| 2017 Q1 | 321,819 | $821,000 | +$129,668 | $2.56 | 10 |
| 2016 Q4 | 352,476 | $574,000 | -$447,607 | $1.62 | 8 |
| 2016 Q3 | 626,176 | $1,038,000 | +$106,118 | $1.74 | 9 |
| 2016 Q2 | 529,176 | $1,372,000 | +$1,134,798 | $2.62 | 10 |
| 2016 Q1 | 88,895 | $273,000 | -$722,998 | $3.05 | 6 |
| 2015 Q4 | 360,429 | $987,000 | -$31,356 | $2.73 | 6 |
| 2015 Q3 | 371,248 | $1,059,000 | +$1,059,000 | $2.85 | 6 |